Taylor Morrison Home Corporation (TMHC) Stock Competitors & Peer Comparison
See (TMHC) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMHC | $71.86 | +0.18% | 6.6B | 10.04 | $7.16 | N/A |
| DHI | $158.57 | +0.96% | 45B | 14.86 | $10.67 | +1.10% |
| PHM | $133.67 | +0.81% | 25.5B | 12.90 | $10.36 | +0.75% |
| LEN | $88.21 | +1.32% | 21.9B | 14.46 | $6.10 | +2.27% |
| LEN-B | $86.27 | +1.45% | 21.9B | 13.44 | $6.42 | +2.27% |
| NVR | $6,750.79 | +1.61% | 18.2B | 30.30 | $222.76 | N/A |
| TOL | $157.14 | -0.15% | 14.7B | 11.89 | $13.22 | +0.64% |
| IBP | $228.26 | +1.89% | 6.1B | 20.45 | $11.16 | +1.45% |
| MTH | $81.86 | +0.38% | 5.5B | 13.73 | $5.96 | +2.22% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
Stock Comparison
TMHC vs DHI Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, DHI has a market cap of 45B. Regarding current trading prices, TMHC is priced at $71.86, while DHI trades at $158.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas DHI's P/E ratio is 14.86. In terms of profitability, TMHC's ROE is +0.11%, compared to DHI's ROE of +0.13%. Regarding short-term risk, TMHC is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DHI's competition here
TMHC vs PHM Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, PHM has a market cap of 25.5B. Regarding current trading prices, TMHC is priced at $71.86, while PHM trades at $133.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas PHM's P/E ratio is 12.90. In terms of profitability, TMHC's ROE is +0.11%, compared to PHM's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check PHM's competition here
TMHC vs LEN Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, LEN has a market cap of 21.9B. Regarding current trading prices, TMHC is priced at $71.86, while LEN trades at $88.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas LEN's P/E ratio is 14.46. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN's competition here
TMHC vs LEN-B Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, LEN-B has a market cap of 21.9B. Regarding current trading prices, TMHC is priced at $71.86, while LEN-B trades at $86.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas LEN-B's P/E ratio is 13.44. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN-B's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to LEN-B. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN-B's competition here
TMHC vs NVR Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, NVR has a market cap of 18.2B. Regarding current trading prices, TMHC is priced at $71.86, while NVR trades at $6,750.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas NVR's P/E ratio is 30.30. In terms of profitability, TMHC's ROE is +0.11%, compared to NVR's ROE of +0.33%. Regarding short-term risk, TMHC is less volatile compared to NVR. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check NVR's competition here
TMHC vs TOL Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, TOL has a market cap of 14.7B. Regarding current trading prices, TMHC is priced at $71.86, while TOL trades at $157.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas TOL's P/E ratio is 11.89. In terms of profitability, TMHC's ROE is +0.11%, compared to TOL's ROE of +0.15%. Regarding short-term risk, TMHC is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check TOL's competition here
TMHC vs IBP Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, IBP has a market cap of 6.1B. Regarding current trading prices, TMHC is priced at $71.86, while IBP trades at $228.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas IBP's P/E ratio is 20.45. In terms of profitability, TMHC's ROE is +0.11%, compared to IBP's ROE of +0.37%. Regarding short-term risk, TMHC is less volatile compared to IBP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check IBP's competition here
TMHC vs MTH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, MTH has a market cap of 5.5B. Regarding current trading prices, TMHC is priced at $71.86, while MTH trades at $81.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas MTH's P/E ratio is 13.73. In terms of profitability, TMHC's ROE is +0.11%, compared to MTH's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MTH's competition here
TMHC vs MDC Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, TMHC is priced at $71.86, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas MDC's P/E ratio is 11.91. In terms of profitability, TMHC's ROE is +0.11%, compared to MDC's ROE of +0.02%. Regarding short-term risk, TMHC is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check MDC's competition here
TMHC vs SKY Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, SKY has a market cap of 4.7B. Regarding current trading prices, TMHC is priced at $71.86, while SKY trades at $85.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas SKY's P/E ratio is 22.14. In terms of profitability, TMHC's ROE is +0.11%, compared to SKY's ROE of +0.13%. Regarding short-term risk, TMHC is less volatile compared to SKY. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SKY's competition here
TMHC vs CVCO Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, CVCO has a market cap of 4.6B. Regarding current trading prices, TMHC is priced at $71.86, while CVCO trades at $598.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas CVCO's P/E ratio is 24.98. In terms of profitability, TMHC's ROE is +0.11%, compared to CVCO's ROE of +0.18%. Regarding short-term risk, TMHC is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CVCO's competition here
TMHC vs MHO Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, MHO has a market cap of 4B. Regarding current trading prices, TMHC is priced at $71.86, while MHO trades at $156.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas MHO's P/E ratio is 10.44. In terms of profitability, TMHC's ROE is +0.11%, compared to MHO's ROE of +0.11%. Regarding short-term risk, TMHC is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MHO's competition here
TMHC vs TPH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, TMHC is priced at $71.86, while TPH trades at $46.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas TPH's P/E ratio is 22.36. In terms of profitability, TMHC's ROE is +0.11%, compared to TPH's ROE of +0.06%. Regarding short-term risk, TMHC is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check TPH's competition here
TMHC vs KBH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, KBH has a market cap of 3.8B. Regarding current trading prices, TMHC is priced at $71.86, while KBH trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas KBH's P/E ratio is 12.04. In terms of profitability, TMHC's ROE is +0.11%, compared to KBH's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check KBH's competition here
TMHC vs GRBK-PA Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, GRBK-PA has a market cap of 3.6B. Regarding current trading prices, TMHC is priced at $71.86, while GRBK-PA trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas GRBK-PA's P/E ratio is 3.34. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK-PA's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to GRBK-PA. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check GRBK-PA's competition here
TMHC vs GRBK Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, GRBK has a market cap of 3.4B. Regarding current trading prices, TMHC is priced at $71.86, while GRBK trades at $79.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas GRBK's P/E ratio is 11.67. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check GRBK's competition here
TMHC vs HOVNP Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, HOVNP has a market cap of 2.9B. Regarding current trading prices, TMHC is priced at $71.86, while HOVNP trades at $19.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas HOVNP's P/E ratio is 2.69. In terms of profitability, TMHC's ROE is +0.11%, compared to HOVNP's ROE of +0.04%. Regarding short-term risk, TMHC is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check HOVNP's competition here
TMHC vs CCS Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, CCS has a market cap of 2B. Regarding current trading prices, TMHC is priced at $71.86, while CCS trades at $69.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas CCS's P/E ratio is 13.06. In terms of profitability, TMHC's ROE is +0.11%, compared to CCS's ROE of +0.05%. Regarding short-term risk, TMHC is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CCS's competition here
TMHC vs DFH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, DFH has a market cap of 1.6B. Regarding current trading prices, TMHC is priced at $71.86, while DFH trades at $16.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas DFH's P/E ratio is 9.74. In terms of profitability, TMHC's ROE is +0.11%, compared to DFH's ROE of +0.11%. Regarding short-term risk, TMHC is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DFH's competition here
TMHC vs LGIH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, LGIH has a market cap of 1.4B. Regarding current trading prices, TMHC is priced at $71.86, while LGIH trades at $62.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas LGIH's P/E ratio is 18.14. In terms of profitability, TMHC's ROE is +0.11%, compared to LGIH's ROE of +0.03%. Regarding short-term risk, TMHC is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LGIH's competition here
TMHC vs BZH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, BZH has a market cap of 767.3M. Regarding current trading prices, TMHC is priced at $71.86, while BZH trades at $28.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas BZH's P/E ratio is 70.18. In terms of profitability, TMHC's ROE is +0.11%, compared to BZH's ROE of -0.00%. Regarding short-term risk, TMHC is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check BZH's competition here
TMHC vs HOV Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, HOV has a market cap of 682.3M. Regarding current trading prices, TMHC is priced at $71.86, while HOV trades at $134.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas HOV's P/E ratio is 13.31. In terms of profitability, TMHC's ROE is +0.11%, compared to HOV's ROE of +0.04%. Regarding short-term risk, TMHC is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOV's competition here
TMHC vs LEGH Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, LEGH has a market cap of 627.4M. Regarding current trading prices, TMHC is priced at $71.86, while LEGH trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas LEGH's P/E ratio is 14.82. In terms of profitability, TMHC's ROE is +0.11%, compared to LEGH's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEGH's competition here
TMHC vs SIC Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, TMHC is priced at $71.86, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas SIC's P/E ratio is 7.11. In terms of profitability, TMHC's ROE is +0.11%, compared to SIC's ROE of -0.06%. Regarding short-term risk, TMHC is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SIC's competition here
TMHC vs UHG Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, UHG has a market cap of 71.8M. Regarding current trading prices, TMHC is priced at $71.86, while UHG trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas UHG's P/E ratio is -4.36. In terms of profitability, TMHC's ROE is +0.11%, compared to UHG's ROE of -0.23%. Regarding short-term risk, TMHC is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check UHG's competition here
TMHC vs SPHL Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, SPHL has a market cap of 4.2M. Regarding current trading prices, TMHC is priced at $71.86, while SPHL trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas SPHL's P/E ratio is -16.00. In terms of profitability, TMHC's ROE is +0.11%, compared to SPHL's ROE of -0.37%. Regarding short-term risk, TMHC is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SPHL's competition here
TMHC vs NWHM Comparison July 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.6B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, TMHC is priced at $71.86, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.04, whereas NWHM's P/E ratio is N/A. In terms of profitability, TMHC's ROE is +0.11%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, TMHC is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check NWHM's competition here